ELITEIMMUNE

Our second headquarter is located in the Tianjin International Joint Academy of Biomedicine, the core and landmark of Bio-Med Zone of Binhai New Area, Tianjin, China. The headquarter in China is equal in stature to our home base in the US. EliteImmune is committed to delivering the most innovative and effective therapeutics from our dual R&D engines advancing the quality of human health... EliteImmune focuses on creating antibody-based drugs for targeted therapy and prophylaxis of infectious diseases. Powered by our proprietary CellProbe™ and CellSeq™ platforms, we pinpoint naturally occurring leads by high-resolution and high-throughput screening of B cell repertoires from elite donors. We have a robust pipeline of rare antibodies with superior selectivity, affinity, and therapeutic efficacy to combat deadly infectious diseases.

Also known as: EliteImmune Corporation